It’s 2018 – some important events to watch out for this year

Happy New Year to you all. To get your year off to a good start, here are a few important dates for your new 2018 diary. February 1 – 3 ACTRIMS Forum, San Diego, California, USA The third annual Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum is themed “Therapeutic Targets in … Continue reading It’s 2018 – some important events to watch out for this year

Ibudilast slows both brain shrinkage and loss of myelin in MS, phase 2 trial shows

Multiple sclerosis organisations, and the media, are excited about new drug ibudilast. This follows a striking presentation at the ECTRIMS-ACTRIMS meeting in Paris. So, what exactly is ibudilast and what can it do? Well, it’s an ant-inflammatory treatment but, for a more detailed answer, I am grateful to multiplescleroisnewstoday.com for this explanation: “Ibudilast, labeled MN-166 by MediciNova, is … Continue reading Ibudilast slows both brain shrinkage and loss of myelin in MS, phase 2 trial shows